<DOC>
	<DOCNO>NCT01647958</DOCNO>
	<brief_summary>The purpose study assess efficacy safety Transoral Incisionless Fundoplication ( TIF ) perform EsophyX compare proton pump inhibitor ( PPI ) therapy treatment chronic Gastroesophageal Reflux Disease ( GERD ) patient refractory symptom Proton Pump Inhibitors ( PPIs ) .</brief_summary>
	<brief_title>The EndoGastric Solutions TEMPO Trial</brief_title>
	<detailed_description>The objective study assess efficacy safety TIF perform EsophyX compare proton pump inhibitor ( PPI ) therapy treatment chronic GERD patient medically refractory GERD symptom heartburn . Primary hypothesis : TIF superior PPIs eliminate significantly improve daily bothersome GERD symptom and/or troublesome regurgitation , present , 6-month follow-up . Secondary hypothesis : TIF superior PPIs eliminate significantly improve daily bothersome GERD symptom and/or troublesome regurgitation , present , 12- , 24- , 36- , 48- 60-month follow-up . The majority surgical patient normalize 50 % improved esophageal acid exposure compare baseline 6-month follow-up . The majority surgical patient completely PPIs 6- , 12- , 24- , 36- , 48- 60-month follow-up compare baseline . The majority crossover patient completely PPIs 6- , 18- , 30- , 42- 54-month follow-up compare baseline . A statistically great proportion crossover patient treat TIF free daily bothersome symptom ( ) experience clinically significant improvement 6- , 18- , 30- , 42- 54-month follow-up .</detailed_description>
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Proton Pump Inhibitors</mesh_term>
	<criteria>1 . Age 1880 year ; 2 . GERD &gt; 1 year ; 3 . History daily PPIs &gt; 6 month ; 4 . At least daily bothersome medically refractory GERD symptom ( ) heartburn PPIs ; 5 . Hill grade I II gastroesophageal junction ; 6 . Proven gastroesophageal reflux either endoscopy , ambulatory pH barium swallow testing ; 7 . Willingness undergo pH testing ; 8 . Willingness cooperate postoperative diet ; 9 . Availability followup visit 6 , 12 , 24 , 36 month ; 10 . Willingly cognitively sign inform consent 1 . BMI &gt; 35 Hiatal hernia &gt; 2c axial height &gt; 2 cm great transverse dimension ; 2 . Esophagitis grade C D ; 3 . Barrett 's esophagus &gt; 2 cm ; 4 . Esophageal ulcer ; 5 . Fixed esophageal stricture narrowing ; 6 . Portal hypertension and/or varix ; 7 . Active gastroduodenal ulcer disease ; Gastric outlet obstruction stenosis ; 8 . Gastroparesis ; 9 . Coagulation disorder ; 10 . History follow : resective gastric esophageal surgery , antireflux surgery anatomy unsuitable TIF procedure per physician judgment , cervical spine fusion , Zenker 's diverticulum , esophageal epiphrenic diverticulum , achalasia , scleroderma dermatomyositis , eosinophilic esophagitis , cirrhosis ; 11 . Pregnancy plan pregnancy next 12 month ; 12 . Enrollment another device drug study may confound result</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>TEMPO</keyword>
	<keyword>TIF</keyword>
	<keyword>Transoral Incisionless Fundoplication</keyword>
	<keyword>EsophyX System</keyword>
	<keyword>refractory symptom</keyword>
	<keyword>proton pump inhibitor</keyword>
	<keyword>EndoGastric Solutions</keyword>
	<keyword>EGS</keyword>
	<keyword>Acid Reflux</keyword>
	<keyword>Heartburn</keyword>
	<keyword>Regurgitation</keyword>
</DOC>